Skip to content

NAVEAU-SMEETS: what changed

BE 0436.294.716NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€36,203
2024 · -€15,751+€51,955
Equity
€272,281
2024 · €236,078+€36,203
Cash
€183,876
2024 · €217,489-€33,613
Balance sheet total
€552,659
2024 · €552,076+€582

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€36,518

    up €36,518 (+25.4%), from €143,874 to €180,392

    of which Trade receivables: +€32,101

  • Cash -€33,613

    down €33,613 (-15.5%), from €217,489 to €183,876

    mainly Other debts (-€40,814) and Receivables within one year (-€36,518)

  • Deferred charges and accrued income -€7,777

    down €7,777 (-50.6%), from €15,355 to €7,579

  • Stocks and contracts +€6,483

    up €6,483 (+3.9%), from €168,212 to €174,695

Equity and liabilities
  • Other debts -€40,814

    down €40,814 (-82.6%), from €49,382 to €8,569

  • Profit (loss) carried forward +€32,462

    no longer reported in 2025 (was -€32,462)

  • Tax, wage and social debts +€22,298

    up €22,298 (+103%), from €21,598 to €43,896

    of which Remuneration and social security: +€12,408

  • Trade debts -€16,757

    down €16,757 (-7.0%), from €238,441 to €221,684

Income statement
  • Gross operating margin +€53,358

    up €53,358 (+29.0%), from €184,030 to €237,388

  • Taxes +€7,266

    new in 2025: €7,266

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€15,751
Gross operating margin +€53,358
Staff costs +€1,591
Depreciation +€861
Other operating charges +€334
Financial income +€1,346
Financial charges +€1,731
Taxes -€7,266
Result 2025 €36,203
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€34,344
Investment -€199
Financing +€930
Cash 2024 €217,489
Net result for the year +€36,203
Depreciation +€1,227
Stocks and contracts -€6,483
Receivables within one year -€36,518
Deferred charges and accrued income +€7,777
Trade debts -€16,757
Tax, wage and social debts +€22,298
Other debts -€40,814
Accrued charges and deferred income -€1,278
Current investments -€199
Short-term financial debts +€930
Cash 2025 €183,876
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €552,076 €552,659 +€582 +0.1%
Fixed assets 21/28 €7,146 €5,919 -€1,227 -17.2%
Tangible fixed assets 22/27 €2,146 €919 -€1,227 -57.2%
Plant, machinery and equipment 23 €666 - -€666
Furniture and vehicles 24 €1,480 €919 -€561 -37.9%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €544,930 €546,740 +€1,810 +0.3%
Stocks and contracts in progress 3 €168,212 €174,695 +€6,483 +3.9%
Stocks 30/36 €168,212 €174,695 +€6,483 +3.9%
Amounts receivable within one year 40/41 €143,874 €180,392 +€36,518 +25.4%
Trade receivables 40 €143,845 €175,945 +€32,101 +22.3%
Other amounts receivable 41 €29 €4,447 +€4,417 +15,144%
Current investments 50/53 - €199 +€199
Cash at bank and in hand 54/58 €217,489 €183,876 -€33,613 -15.5%
Deferred charges and accrued income 490/1 €15,355 €7,579 -€7,777 -50.6%
Total equity and liabilities 10/49 €552,076 €552,659 +€582 +0.1%
Equity 10/15 €236,078 €272,281 +€36,203 +15.3%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €249,947 €253,689 +€3,742 +1.5%
Tax-exempt reserves 132 €22 €22 = 0.0%
Distributable reserves 133 €249,925 €253,667 +€3,742 +1.5%
Profit (loss) carried forward 14 -€32,462 - +€32,462
Amounts payable 17/49 €315,998 €280,378 -€35,621 -11.3%
Amounts payable within one year 42/48 €309,421 €275,079 -€34,342 -11.1%
Financial debts 43 - €930 +€930
Other loans 439 - €930 +€930
Trade debts 44 €238,441 €221,684 -€16,757 -7.0%
Suppliers 440/4 €238,441 €221,684 -€16,757 -7.0%
Taxes, remuneration and social security 45 €21,598 €43,896 +€22,298 +103%
Taxes 450/3 €204 €10,095 +€9,890 +4,845%
Remuneration and social security 454/9 €21,394 €33,801 +€12,408 +58.0%
Other amounts payable 47/48 €49,382 €8,569 -€40,814 -82.6%
Accrued charges and deferred income 492/3 €6,577 €5,299 -€1,278 -19.4%
Remuneration, social security and pensions 62 €181,473 €179,883 -€1,591 -0.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,088 €1,227 -€861 -41.2%
Other operating charges 640/8 €780 €446 -€334 -42.8%
Gross operating margin 9900 €184,030 €237,388 +€53,358 +29.0%
Operating profit (loss) 9901 -€311 €55,832 +€56,143
Financial income 75/76B €23 €1,368 +€1,346 +5,976%
Recurring financial income 75 €23 €1,368 +€1,346 +5,976%
Financial charges 65/66B €15,463 €13,732 -€1,731 -11.2%
Recurring financial charges 65 €15,463 €13,732 -€1,731 -11.2%
Profit (loss) for the period before taxes 9903 -€15,751 €43,469 +€59,220
Income taxes 67/77 - €7,266 +€7,266
Profit (loss) for the period 9904 -€15,751 €36,203 +€51,955
Profit (loss) for the period to be appropriated 9905 -€15,751 €36,203 +€51,955

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€168,201 to €181,026

Midpoint €173,545 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €272,281
Capitalised earnings €64,121 to €89,770
Indication €168,201 to €181,026

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€272,281
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€272,281

Capitalised earnings

net result for the year (9904)
2025
€36,203
2024
-€15,751
2023
€6,479
2022
-€23,190
2021
€37,678
Average result
€8,977
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€64,121 / €74,808 / €89,770

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 12 November 2026 via checked.be.